Swiss dermatology focused biopharma Galderma today announced new data from the OLYMPIA open-label extension study ...

Latin America is making steady progress in harmonizing its regulatory frameworks and strengthening participation in ...

US biotech Earendil Labs has entered a strategic collaboration with Hong Kong-listed WuXi XDC (HKEX: 2268), securing an ...

Chinese drugmaker Jiuyuan Genetic Biopharmaceutical (HKEX: 2566) has applied for approval to market its biosimilar version of ...

German family-owned pharma major Boehringer Ingelheim and UK clinical stage biotech Sitryx Therapeutics announced that ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Hernexeos (zongertinib), from German family ...

Germany’s Bayer has announced encouraging results from the ongoing global Phase I first-in-human dose-escalation PAnTHa study of 225Ac-PSMA-Trillium, a targeted alpha therapy in advanced metastatic ca ...

Switzerland’s Santhera Pharmaceuticals has announced that the Spanish Interministerial Commission on Prices of Medicines has proposed to include Agamree (vamorolone) in the pharmaceutical coverage of ...

Atrium Therapeutics launched today as a newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, ...

Hungary’s largest drugmaker Gedeon Richter today published financial results for 2025, showing that pharmaceutical revenues increased by 12.5% year-on-year to 245.2 billion forint ($771) in the fourth ...

US drugmaker Eli Lilly (NYSE: LLY) has launched a new NVIDIA-powered supercomputer, dubbed LillyPod, as part of a broader effort to embed artificial intelligence across its research and manufacturing ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended 6 novel medicines for approval at its February 2026 meeting. These now have to be approved by the European Commission ...